We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XERS icon
901
Xeris Biopharma Holdings
XERS
$1.34B
$1.84M 0.01%
234,723
-69,781
-23% -$549K
ASML icon
902
ASML
ASML
$666B
$1.83M 0.01%
1,710
-10,801
-86% -$11.3M
ANDG
903
Andersen Group
ANDG
$5.61B
$1.83M 0.01%
+70,392
New +$1.77M
IPCX
904
Inflection Point Acquisition Corp III
IPCX
$152M
$1.83M 0.01%
180,000
+20,025
+13% +$203K
EZPW icon
905
Ezcorp Inc
EZPW
$1.73B
$1.81M 0.01%
93,267
+3,452
+4% +$65.1K
MLYS icon
906
Mineralys Therapeutics
MLYS
$2.39B
$1.81M 0.01%
49,821
+35,203
+241% +$1.41M
BLZRU
907
Trailblazer Acquisition Corp Unit
BLZRU
$205M
$1.8M 0.01%
176,061
-28,690
-14% -$295K
SONO icon
908
Sonos
SONO
$1.85B
$1.8M 0.01%
102,679
-128,939
-56% -$2.25M
FAC
909
Factorial Energy Inc
FAC
$658M
$1.8M 0.01%
175,000
-25,000
-13% -$254K
JHG
910
DELISTED
Janus Henderson
JHG
$1.8M 0.01%
+37,827
New +$1.67M
ATII
911
Archimedes Tech SPAC Partners II Co
ATII
$317M
$1.8M 0.01%
173,515
-48,150
-22% -$499K
TAK icon
912
Takeda Pharmaceutical
TAK
$55.7B
$1.8M 0.01%
+115,250
New +$1.65M
CRVL icon
913
CorVel
CRVL
$3.21B
$1.8M 0.01%
26,529
-4,489
-14% -$325K
ADPT icon
914
Adaptive Biotechnologies
ADPT
$3.89B
$1.79M 0.01%
110,452
+89,508
+427% +$1.46M
TTD icon
915
Trade Desk
TTD
$6.55B
$1.78M 0.01%
46,834
-281,805
-86% -$12.5M
BIPC icon
916
Brookfield Infrastructure
BIPC
$4.9B
$1.78M 0.01%
39,143
-426
-1% -$19.3K
DY icon
917
Dycom Industries
DY
$12.2B
$1.77M 0.01%
+5,248
New +$1.65M
BTG icon
918
B2Gold
BTG
$6.72B
$1.77M 0.01%
391,553
-99,763
-20% -$465K
PSX icon
919
Phillips 66
PSX
$82B
$1.75M 0.01%
+13,572
New +$1.83M
WYNN icon
920
Wynn Resorts
WYNN
$10.6B
$1.73M 0.01%
14,389
+14,381
+179,763% +$1.78M
GFI icon
921
Gold Fields
GFI
$36.9B
$1.73M 0.01%
39,643
-109,165
-73% -$4.56M
ZTS icon
922
Zoetis
ZTS
$30.8B
$1.72M 0.01%
13,687
-10,678
-44% -$1.39M
WAY
923
Waystar Holding Corp
WAY
$4.69B
$1.72M 0.01%
52,498
+13,799
+36% +$492K
FYBR
924
DELISTED
Frontier Communications
FYBR
$1.71M 0.01%
45,040
+6,360
+16% +$240K
AMD icon
925
CALL
Advanced Micro Devices
AMD
$788B
$1.71M 0.01%
+8,000
New +$1.8M

Similar funds

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.